212 related articles for article (PubMed ID: 16954373)
1. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
2. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
To KK; Polgar O; Huff LM; Morisaki K; Bates SE
Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
[TBL] [Abstract][Full Text] [Related]
3. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
[TBL] [Abstract][Full Text] [Related]
5. Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.
Saito J; Hirota T; Furuta S; Kobayashi D; Takane H; Ieiri I
PLoS One; 2013; 8(8):e72906. PubMed ID: 23991164
[TBL] [Abstract][Full Text] [Related]
6. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.
Xiang N; Zhao R; Song G; Zhong W
Carcinogenesis; 2008 Nov; 29(11):2175-81. PubMed ID: 18676679
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma.
Schelleckes K; Schmitz B; Ciarimboli G; Lenders M; Pavenstädt HJ; Herrmann E; Brand SM; Brand E
Clin Epigenetics; 2017; 9():109. PubMed ID: 29046731
[TBL] [Abstract][Full Text] [Related]
8. Differential promoter methylation and histone modification contribute to the brain specific expression of the mouse Mbu-1 gene.
Kim B; Kang S; Kim SJ
Mol Cells; 2012 Nov; 34(5):433-7. PubMed ID: 23076708
[TBL] [Abstract][Full Text] [Related]
9. Methylation of CpG islands in the rat 7-dehydrocholesterol reductase promoter suppresses transcriptional activation.
Kim JH; Hwang EH; Park HJ; Paik YK; Shim YH
Mol Cells; 2005 Apr; 19(2):279-82. PubMed ID: 15879714
[TBL] [Abstract][Full Text] [Related]
10. De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands.
Masalmeh RHA; Taglini F; Rubio-Ramon C; Musialik KI; Higham J; Davidson-Smith H; Kafetzopoulos I; Pawlicka KP; Finan HM; Clark R; Wills J; Finch AJ; Murphy L; Sproul D
Nat Commun; 2021 Jan; 12(1):694. PubMed ID: 33514701
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter.
Rice JC; Futscher BW
Nucleic Acids Res; 2000 Sep; 28(17):3233-9. PubMed ID: 10954590
[TBL] [Abstract][Full Text] [Related]
12. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
[TBL] [Abstract][Full Text] [Related]
13. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
[TBL] [Abstract][Full Text] [Related]
14. The CpG island encompassing the promoter and first exon of human DNMT3L gene is a PcG/TrX response element (PRE).
Basu A; Dasari V; Mishra RK; Khosla S
PLoS One; 2014; 9(4):e93561. PubMed ID: 24743422
[TBL] [Abstract][Full Text] [Related]
15. Methylation of neutral endopeptidase 24.11 promoter in rat hepatocellular carcinoma.
Uematsu F; Takahashi M; Yoshida M; Igarashi M; Nakae D
Cancer Sci; 2006 Jul; 97(7):611-7. PubMed ID: 16827801
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.
Shin JE; Park SH; Jang YK
Mol Cells; 2011 Feb; 31(2):181-9. PubMed ID: 21191816
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.
Hamai Y; Oue N; Mitani Y; Nakayama H; Ito R; Matsusaki K; Yoshida K; Toge T; Yasui W
Cancer Sci; 2003 Aug; 94(8):692-8. PubMed ID: 12901794
[TBL] [Abstract][Full Text] [Related]
18. Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway.
An HJ; Lee H; Paik SG
Mol Cells; 2011 Jun; 31(6):579-83. PubMed ID: 21573703
[TBL] [Abstract][Full Text] [Related]
19. iChIP-SILAC analysis identifies epigenetic regulators of CpG methylation of the p16
Fujita T; Fujii H
FEBS Lett; 2024 May; 598(9):1094-1109. PubMed ID: 38627195
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease.
El-Osta A; Wolffe AP
Gene Expr; 2000; 9(1-2):63-75. PubMed ID: 11097425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
